Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Douglas Bolgiano"'
Autor:
Philip J. Norris, Sherrill J. Slichter, Jar How Lee, Douglas Bolgiano, Rachael P. Jackman, Rui Pei, Mila Lebedeva
Publikováno v:
Transfusion. 56:1442-1450
BACKGROUND In the Trial to Reduce Alloimmunization to Platelets (TRAP) study, 101 of 530 subjects became clinically refractory (CR) to platelets (PLTs) without lymphocytotoxicity assay (LCA)-detectable anti-HLA antibodies. The LCA only detects comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78ff243cc6757b6222cf723d8cafd95b
https://doi.org/10.1111/trf.13598
https://doi.org/10.1111/trf.13598
Publikováno v:
Transfusion. 56:489-496
BACKGROUND Methods used to produce platelet (PLT) components, pooling of PLT-rich plasma (PRP-PLT) and apheresis (AP-PLT), may variably contribute to the pathogenesis and severity of idiopathic pneumonia syndrome (IPS). STUDY DESIGN AND METHODS We pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb1815be7ed9b658f8c70e9a1d53e55a
https://doi.org/10.1111/trf.13361
https://doi.org/10.1111/trf.13361
Autor:
Xutao Deng, Harvey Alter, Sherrill J. Slichter, Eva Operskalski, Mila Lebedeva, Philip J. Norris, Garth H. Utter, Cathy Schechterly, Rachael P. Jackman, Douglas Bolgiano, Michael P. Busch, Naomi L. Luban
Publikováno v:
Transfusion. 54:672-680
Background Both leukoreduction and ultraviolet (UV) light treatment of blood products have been shown to reduce the incidence of HLA antibody development in recipients, but the impact of these treatments on the magnitude and persistence of the antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbafcad01f7d381913edb23db9c0ea93
https://doi.org/10.1111/trf.12317
https://doi.org/10.1111/trf.12317
Autor:
Rachael P, Jackman, Jar-How, Lee, Rui, Pei, Douglas, Bolgiano, Mila, Lebedeva, Sherrill J, Slichter, Philip J, Norris
Publikováno v:
Transfusion. 56(6)
In the Trial to Reduce Alloimmunization to Platelets (TRAP) study, 101 of 530 subjects became clinically refractory (CR) to platelets (PLTs) without lymphocytotoxicity assay (LCA)-detectable anti-HLA antibodies. The LCA only detects complement-bindin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9513503894e5b72f83834681862aa754
https://pubmed.ncbi.nlm.nih.gov/27079754
https://pubmed.ncbi.nlm.nih.gov/27079754
Autor:
Adam Cuker, Lubica Rauova, William H. Matthai, Mortimer Poncz, Barbara A. Konkle, Douglas Bolgiano
Publikováno v:
Thrombosis and Haemostasis. 111:1191-1193
Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2425314a28cee02b53786d243dff70
https://doi.org/10.1160/th13-12-1012
https://doi.org/10.1160/th13-12-1012
Autor:
Lakshmi K. Gaur, April Stempien-Otero, Alexander P. Reiner, Douglas Bolgiano, Karen Nelson, Kevin D. O'Brien, Wayne C. Levy, Jian Qing He
Publikováno v:
The Journal of Heart and Lung Transplantation. 21:629-636
Background The occurrence of coronary artery disease (CAD) after heart transplantation may represent an accelerated inflammatory and thrombotic response to coronary vascular endothelial cell injury. Several common mutations involving hemostasis and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba474f89638d1e512b98ce3e2ea991e
https://doi.org/10.1016/s1053-2498(01)00409-0
https://doi.org/10.1016/s1053-2498(01)00409-0
Autor:
Barbara A. Konkle, Neil C. Josephson, Arthur R. Thompson, Douglas Bolgiano, D. Nance, Shelley N Fletcher
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 19(5)
Summary Utilization of the synthetic vasopressin analogue (1-deamino-8-D-arginine-vasopressin, DDAVP) in treatment of mild haemophilia A (MHA, specific clotting factor VIII activity level 0.05–0.4 IU mL−1) is convenient and effective for many but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af81fde4d64f543525861b1098c1502a
https://pubmed.ncbi.nlm.nih.gov/23711294
https://pubmed.ncbi.nlm.nih.gov/23711294
Autor:
Rachael P, Jackman, Xutao, Deng, Douglas, Bolgiano, Garth H, Utter, Cathy, Schechterly, Mila, Lebedeva, Eva, Operskalski, Naomi L, Luban, Harvey, Alter, Michael P, Busch, Sherrill J, Slichter, Philip J, Norris
Publikováno v:
Transfusion. 54(3)
Both leukoreduction and ultraviolet (UV) light treatment of blood products have been shown to reduce the incidence of HLA antibody development in recipients, but the impact of these treatments on the magnitude and persistence of the antibody response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57bc92e1d9853650c9458d6e82c0f230
https://pubmed.ncbi.nlm.nih.gov/23808544
https://pubmed.ncbi.nlm.nih.gov/23808544
Autor:
Philip J. Norris, John W. Heitman, Rachael P. Jackman, Xutao Deng, Sherrill J. Slichter, Michael P. Busch, Douglas Bolgiano, Mila Lebedeva
Publikováno v:
Blood. 121(16)
In the Trial to Reduce Alloimmunization to Platelets (TRAP) study, 101 of 530 participants became refractory to platelet transfusions without evidence of HLA or human platelet antigen (HPA) antibodies. We used a more sensitive bead-based assay to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67bad2ede06821cf27293721cd27ced3
https://pubmed.ncbi.nlm.nih.gov/23393051
https://pubmed.ncbi.nlm.nih.gov/23393051
Autor:
Thomas H. Price, Ronald A. Sacher, Lawrence T. Goodnough, William R. Vogler, Marilyn F. M. Johnston, Richard Hellman, Robert I. Abels, Douglas Bolgiano
Publikováno v:
The American Journal of Medicine. 101:22S-27S
The effects of therapy with recombinant human erythropoietin (Epoetin alfa) on erythropoiesis, preoperative autologous blood donation, and risk of exposure to allogeneic blood were evaluated in 204 patients scheduled to undergo elective orthopedic su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641f9553e951ac6889fb04bb70c131ad
https://doi.org/10.1016/s0002-9343(96)00165-9
https://doi.org/10.1016/s0002-9343(96)00165-9